Add-on topiramate in the treatment of refractory partial-onset epilepsy: Clinical experience of outpatient epilepsy clinics from 11 general hospitals

Seizure

Volumn 14, Issue 6, 2005, Pages 396-402

  Giannakodimos, St ^a   Georgiadis, G ^b   Tsounis, St ^c   Triantafillou, N ^d   Kimiskidis, V ^e   Giatas, K ^f   Karlovasitou, A ^c   Mitsikostas, D D ^g   Thodi, E ^h   Polychronopoulos, P ⁱ   Ramopoulos, N ^j   Michailidis, K ^j   Michalis, N ^j   Garganis, K ^c   Gatzonis, St ^d   Balogiannis, St ^c   Kazis, Ar ^e   Milonas, J ^c   Van Oene, J C ^h  

^a KAT HOSPITAL   (Greece)

^b PAPAGEORGIOU GENERAL HOSPITAL   (Greece)

^c AHEPA UNIVERSITY HOSPITAL   (Greece)

^d NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^e G PAPANICOLAOU HOSPITAL   (Greece)

^f IASO GENERAL HOSPITAL   (Greece)

^g ATHENS NAVAL HOSPITAL   (Greece)

^h IKA ^*  (Netherlands)

ⁱ UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^j Department of Nephrology   (Greece)

more..

Author keywords

Add on therapy; AED refractoriness; Antiepileptic treatment; Partial epilepsy; Topiramate

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; OXCARBAZEPINE; PHENYTOIN; TOPIRAMATE; VALPROIC ACID;

ADD ON THERAPY; ADULT; ANOREXIA; ANXIETY; ARTICLE; DEPRESSION; DISEASE EXACERBATION; DIZZINESS; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG TOLERABILITY; FATIGUE; FEMALE; FOCAL EPILEPSY; FOLLOW UP; GENERAL HOSPITAL; GREECE; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MENTAL INSTABILITY; NERVOUSNESS; OPTIMAL DRUG DOSE; OUTPATIENT; PARESTHESIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; SIDE EFFECT; SOMNOLENCE; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; EPILEPSIES, PARTIAL; FEMALE; FRUCTOSE; HOSPITALS, GENERAL; HUMANS; MALE; MIDDLE AGED; OUTPATIENT CLINICS, HOSPITAL; PROSPECTIVE STUDIES;

EID: 23944489552     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2005.05.006     Document Type: Article

References (20)

1. A.G. Marson Z.A. Kadir D.W. Chadwick New antiepileptic drugs: A systematic review of their efficacy and tolerability Br Med J 313 1996 1169-1174
2. A.J.A. Elferink B.J. Van Zwieten-Boot Analysis based on number needed to treat shows differences between drugs studied Br Med J 314 1997 603
3. M. Sharief C. Viteri E. Ben-Menachem M. Weber R. Reife G. Pledger et al. Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy Epilepsy Res 25 1996 217-224
4. J.W.A.S. Sander Practical aspects of the use of topiramate in patients with epilepsy Epilepsia 38 1997 556-558
5. R.C. Sachdeo R.A. Reife P. Lim G. Pledger Topiramate monotherapy for partial onset seizures Epilepsia 38 1997 294-300
6. F.G. Gilliam F. Veloso M.A.M. Bomhof S.K. Gazda V. Biton J.P. Ter Bruggen W. Neto C. Bailey G. Pledger S.-C. Wu the Topiramate EPMN 104 Study Group A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy Neurology 60 2003 196-202
7. M.D. Privitera M.J. Brodie R.H. Mattison D.W. Chadwick W. Neto S. Wang EPMN 105 Study Group Topiramate, carbamazepine and valproate monotherapy: Double-blind comparison in newly diagnosed epilepsy Acta Neurol Scand 107 2003 165-175
8. E. Faught B.J. Wilder R.E. Ramsay R.A. Reife L.D. Kramer G.W. Pledger et al. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400- and 600-mg daily dosages Neurology 46 1996 1684-1690
9. E. Ben Menachem O. Henriksen M. Dam M. Mikkelsen D. Schmidt S. Reid et al. Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures Epilepsia 37 1996 539-543
10. C.A. Tassinari R. Michelucci P. Chauvel J. Chodkiewicz S. Shorvon O. Henriksen et al. Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy Epilepsia 37 1996 763-768
11. M. Privitera R. Fincham J. Penry R. Reife L. Kramer G. Pledger et al. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1000-mg daily dosages Neurology 46 1996 1678-1683
12. W. Rosenfeld B. Abou-Khalil R. Reife R. Hegadus G. Pledger Topiramate YF/ YG Study Group Placebo controlled trial of topiramate as adjunctive therapy to carbamazepine or phenytoin for partial-onset epilepsy Epilepsia 37 Suppl 5 1996 153
13. International League Against Epilepsy. International classification of epileptic seizures. Epilepsia 1981;22:489-501.
14. PRI. Topamax (topiramate) Epilepsy Product Monograph; 2000.
15. K. Peeters I. Adriaenssen R. Wapenaar W. Neto G. Pledger A pooled analysis of adjunctive topiramate in refractory partial epilepsy Acta Neurol Scand 108 2003 9-15
16. A. Guberman W. Neto C. Gassmann-Mayer the EPAJ-119 Study Group Low-dose topiramate in adults with treatment-resistant partial-onset seizures Acta Neurol Scand 106 2002 183-189
17. R. Reife G. Pledger S.-C. Wu Topiramate as add-on therapy: Pooled analysis of randomized controlled trials in adults Epilepsia 41 Suppl 1 2000 S66-S71
18. S.M. Grant R.C. Heel Vigabatrin: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and motor control Drugs 41 1991 889-926
19. J.W.A.S. Sander P.C. Trevisol-Bittencourt Y.M. Hart P.N. Patsalos S.D. Shorvon The efficacy and long-term tolerability of lamotrigine in the treatment of severe epilepsy Epilepsy Res 7 1990 226-229
20. UK Gabapentin Group. Gabapentin in partial epilepsy. Lancet 1990;335:114-117.